US Clinical Chemistry and Immunodiagnostic Testing Market Analysed in New VPG Report Published at MarketPublishers.com

London, UK (PRWEB) June 10, 2014

At present, the clinical chemistry and immunodiagnostics markets in the US are witnessing considerable transformation, underpinned by the convergence of novel and more stringent regulative policies; ongoing technological advances in the diagnostic field, automation, system engineering and also IT; and also by the constantly intensifying competition in the marketplace. Some market sectors, like routine chemistry, already bear a strong resemblance to commodity markets, where cost per test and product positioning are more essential than underlying technology. The evolving clinical chemistry and immunodiagnostics market opens a range of lucrative opportunities for a great variety of novel instruments, auxiliary products and reagent systems.

Eiken Chemical, Kyowa Medex, Abbott, Biomedical Diagnostics, Roche, Instrumentation Laboratory, Siemens, Bio-Rad, Agilent Technologies, Sysmex, Wako and Beckman Coulter are among the leading companies operating in the US clinical chemistry and immunodiagnostics markets.

New research report 2014 Clinical Chemistry and Immunodiagnostic Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations worked out by Venture Planning Group (VPG) is now available at MarketPublishers.com

Report Details:

Title: 2014 Clinical Chemistry and Immunodiagnostic Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations Published: June, 2014 Pages: 635 Price:US$ 11,500.00 http://marketpublishers.com/report/life_sciences/diagnostics-diseases/2014-clinical-chemistry-n-immunodiagnostic-testing-in-us-hospitals-commercial-laboratories.html

The novel report provides an up-close look at the US clinical chemistry and immunodiagnostic testing market, covers the most important aspects and discusses the burning industry issues. It contains a detailed strategic analysis of the major emerging business opportunities during the next 5 years; investigates the markets future development trends; uncovers data on specimen, tests and sales volumes; and also presents a comparative analysis of the features of top analyzers. Besides, the study describes the competitive scenario and profiles the leading companies engaged in the national clinical chemistry and immunodiagnostic testing market. In addition, the research report contains extensive sales and volume forecasts for more than 100 clinical chemistry, cancer, endocrine, TDM and abused drug assays performed in comer commercial labs, hospitals, cancer clinics, physician offices, ICU, ER, OR, ambulatory care centers, nursing homes, birth centers, surgery centers, etc. in the United States.

Report Scope:

More new market research reports by the publisher can be found at VPG page.

Excerpt from:
US Clinical Chemistry and Immunodiagnostic Testing Market Analysed in New VPG Report Published at MarketPublishers.com